IRTC IRhythm Technologies Inc.

iRhythm Technologies to Provide Commentary on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule

iRhythm Technologies to Provide Commentary on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule

Conference Call and Webcast Scheduled for August 4, 2020 at 1:10 pm PT/4:10 pm ET

SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care will host a conference call today, August 4, 2020 at 1:10 pm PT/4:10 pm ET to provide commentary on the impact to its business of the new codes in the recently released Centers for Medicare and Medicaid Services Calendar Year 2021 Medicare Physician Fee Schedule Proposed Rule.

Webcast Information

Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the “Investors” section of the company’s website at:

About iRhythm Technologies, Inc. 

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Investor Relations Contact:

Lynn Pieper Lewis or Leigh Salvo 

(415) 937-5404

Media Contact

Saige Smith

(262) 289-7065



EN
04/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial...

iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and...

 PRESS RELEASE

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 High...

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exc...

 PRESS RELEASE

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthc...

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on...

 PRESS RELEASE

New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlig...

New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions.Large-scale analysis of more than 400,000 patients1 supports the consistency and generalizability of Zio long-term ECG monitoring (LTCM) performance across populations; median wear and analyzable time among patients identified as Asian (3.4% of the cohort) were comparable to tho...

 PRESS RELEASE

第18回アジア太平洋不整脈学会学術大会(APHRS2025)で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期...

第18回アジア太平洋不整脈学会学術大会(APHRS2025)で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに iRhythm Technologies, Inc.は、アジア太平洋不整脈学会学術大会(APHRS2025)と第71回日本不整脈心電学会学術大会(JHRS2025)の合同学術集会において新しいデータを発表しました。40万人を超える患者を対象とした大規模解析 1 により、長期間の心電図(ECG)モニタリングの性能の一貫性と一般化可能性が裏付けられました。アジア人患者(コホートの3.4%)における中央値の装着時間および解析可能時間は非アジア人患者と同等であり、この結果は既発表のCAMELOT研究2 およびAVALON研究3 で報告されたZio LTCMの性能と一致していました。 サンフランシスコ, Nov. 21, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC) は2025年11月12日から15日まで日本・横浜で開催された第18回アジア太平洋不整脈学会(APHRS)/第71回日本不整脈心電学会学術大会(JHRS2025)合同学術集会において、口頭発表セッションで新たなデータを発表したと明らかにしました。 河田 宏医師の主導のもと、研究チームは米国の大規模患者コホートを対...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch